Welcome to our dedicated page for Nepra Foods news (Ticker: NPRFF), a resource for investors and traders seeking the latest updates and insights on Nepra Foods stock.
Nepra Foods Inc. (NPRFF) generates a steady flow of news as a specialty food and ingredient company focused on plant-based, allergen-free and gluten-free technologies. Company updates frequently highlight its vertically integrated approach to functional nutrition, its work with global food manufacturers and its efforts to expand ingredient sales and distribution partnerships.
Investors and industry followers can use this page to review financial results announcements, including quarterly and annual filings that discuss revenue trends, gross margin performance and cost management. Nepra Foods regularly reports on growth in sales of custom starch ingredients and plant proteins, as well as the impact of production efficiencies and sourcing strategies on profitability metrics.
News items also cover strategic and corporate developments such as board changes, leadership appointments and capital raises through non-brokered private placements. These releases provide insight into the company’s governance priorities, risk management experience on the board and its approach to funding working capital and expansion.
Product and partnership announcements are another key theme. For example, Nepra Foods has disclosed an exclusive North American distribution agreement for UMF-certified Manuka honey produced by Naki New Zealand, positioning the company in a premium functional food category aligned with its mission. Other updates describe rising demand for hemp proteins, functional flours and specialty starches, and the company’s efforts to convert this interest into recurring ingredient revenue.
By following this news feed, readers can track how Nepra Foods executes its strategy in the gluten-free, allergen-free and plant-based ingredient space, including operational progress, financing activities and new commercial relationships that shape its role in the functional food industry.
Nepra Foods (OTCQB:NPRFF) has completed the second and third tranches of its non-brokered private placement offering. The second tranche closed on September 2, 2025, raising US$76,660 through 1,277,667 units at US$0.06 per unit. The third tranche closed on September 10, 2025, raising US$146,341 through 2,439,024 units.
Each unit consists of one common share and one purchase warrant. The warrants allow holders to acquire additional shares at US$0.12 per share until September 2, 2027. The proceeds will be used for general working capital purposes. The securities are subject to a four-month hold period under Canadian securities laws.
Nepra Foods (OTCQB:NPRFF), a leader in gluten-free and plant-based protein solutions, reported strong Q1 2026 financial results with significant improvements across key metrics.
The company achieved revenue of CAD$1.82 million, marking a 39% increase year-over-year. Gross profit surged 141% to CAD$0.56 million, with margins expanding to 31% from 18% in the prior year. Net loss improved substantially, decreasing 60% to CAD$0.34 million. The growth was driven by new customer acquisition and increased starch product sales, while margin improvements resulted from reduced cost of sales and higher-margin blending services.
Nepra Foods (OTCQB:NPRFF), a plant-based and allergen-free food innovator, has filed its annual financial statements for FY2025 ended March 31. The company reported significant growth with revenue increasing 50% to C$6.25 million from C$4.16 million in FY2024.
Notable achievements include a remarkable Q4 2025 revenue surge of 203% to C$2.29 million and improved gross profit margins reaching 21.07% compared to 7.88% in the previous year. The management cease trade order (MCTO) issued by BCSC has been revoked following the successful filing of annual reports.
Nepra Foods (OTCQB:NPRFF) has received a management cease trade order (MCTO) from the British Columbia Securities Commission (BCSC) due to a delay in filing its annual financial statements. The company has been granted an extension until September 29, 2025 to file its Annual Financial Filings for the period ended March 31, 2025.
Under the MCTO, the CEO and CFO are restricted from trading company securities until the filings are completed and the order is revoked. This order does not affect regular shareholders' ability to trade their securities. The company is actively working to complete the required filings before the extended deadline.
Nepra Foods (OTCQB:NPRFF) has announced a delay in filing its annual financial statements for the year ended March 31, 2025. The company missed the required filing deadline of July 29, 2025, as its auditors need additional time to complete their audit.
As a result, Nepra has received a management cease trade order affecting the CEO and CFO's ability to trade company securities. The company expects to file the Annual Filings by August 29, 2025, with a final deadline set for September 29, 2025. In the interim, Nepra will provide bi-weekly default status reports in accordance with National Policy 12-203.
[]Nepra Foods (OTCQB:NPRFF) has completed the first tranche of its non-brokered private placement, raising US$274,000 through the issuance of 4,566,667 units at US$0.06 per unit. Each unit comprises one common share and one warrant, with warrants exercisable at US$0.12 per share until June 27, 2027.
The company expects to close a second tranche around July 11th, 2025. The proceeds will be used for general working capital purposes. The securities are subject to a four-month hold period ending October 26, 2025.
Nepra Foods (OTCQB:NPRFF), a company focused on allergen and gluten-free food ingredient technologies, has announced the resumption of trading on the OTCQB effective April 17, 2025, following approval from OTC Capital Markets. The company has also transitioned to Odyssey Trust Company as its corporate actions representative.
CEO Billy Hogan emphasized the company's commitment to providing shareholders with timely, factual, and complete information regarding its growth in the coming months. Management has expressed gratitude to both OTC Capital Markets and Odyssey for their assistance in facilitating these important transitions.